SOURCE: Crown Dynamics Corp

Crown Dynamics Corp

June 13, 2012 09:00 ET

Crown Dynamics Launches Patented AIR® Sleep/Snore Product Line

Sleep/Snore Product Line to Address Sleep Insomnia and Health Related Issues That Researchers Have Estimated Direct and Indirect Costs at Over $100 Billion a Year

SCOTTSDALE, AZ--(Marketwire - Jun 13, 2012) - Crown Dynamics Corp., (OTCBB: CDYY) today announced the release of its patented AIR® Sleep/Snore product line. The products are infused with a calming proprietary blend of therapeutic essential oils shown to promote sleep while gently dilating nasal passages to help increase oxygen flow and decrease snoring.

"After years of research and development, we're excited that we can deliver to consumers a product that is unlike anything else found in the market today," said David Dolezal, President of Airware Labs. "We're proud to offer our unique AIR® Sleep/Snore product which combines essential oils with our AIR® Breathe product that has been clinically proven to significantly reduce snoring. More and more consumers are looking to natural products for relief from a variety of symptoms. We believe this is the biggest advancement in the over the counter sleep/snore market to date."

The active ingredient is Lavender, an herb used as a remedy for a range of ailments from insomnia and anxiety to depression and fatigue. University of Maryland researchers have confirmed that lavender produces slight calming, soothing, and sedative effects when its scent is inhaled.

While individual suffering is hard to measure, the direct costs of insomnia treatments and healthcare services are estimated to be nearly $14 billion. Indirect costs -- such as work loss and property damage from accidents -- are estimated at $28 billion, according to The National Sleep Foundation. The World Health Organization and Harvard Medical School found that insomnia and poor sleep cost the American economy a staggering $63 billion in lost productivity.

Crown Dynamics' Airware Labs recently published a clinical trial designed to determine the efficacy of its AIR® Breathe products for users and sleep quality for their partners. The product, which acts as an internal nasal dilator as opposed to adhesive nasal strips placed on the outside of the nose, demonstrated substantial alleviation of snoring in AIR® Breathe users, resulting in sounder, more restful sleep for users as well as 88% of their bed partners.

Epidemiologic data indicates that up to 50% of adults snore on a regular basis. Not only is snoring bothersome to bed partners -- who on average lose 2 hours of sleep per night, it has other serious health ramifications. Snoring is an auditory reminder that obstruction of the airway is occurring, a condition that has been linked to cancer, increased blood pressure, heart attack, and stroke.

Additional information on published clinical trial can be found at:

The clinical research findings were published in the September-October issue of Sleep Diagnosis and Therapy, conducted by Dr. Barbara Harris, Dr. Michael Breus, Dr. Thomas Minor and Yiran Hu, MS. Ongoing studies are being conducted on all of the AIR® products.

For more information please see

About Crown Dynamics Corporation
Crown Dynamics provides innovative technology solutions and consumer product offerings that promote better health and enhance the wellbeing of people. Crown Dynamics' products and services, such as AIR® by AirWare Labs, provide consumers around the world with safe and effective methods to control their own personal environment. AIR® filter products contain 3M filters for allergy sufferers and for mass-transit travelers. Other AIR® products help with congestion, insomnia, headaches, nausea and snoring. Crown's Pomcom and Watchtower technology provide point-of-care protection at home or in an assisted living environment. This technology is designed to enhance the personal safety of seniors and people with special needs, allowing them to live fuller, more independent lives.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that involve risks and uncertainties, including the Company's beliefs about its business prospects and future results of operations. These results may not indicative of the result achieved in the entire tailings pile do to the non-homogenous nature of the pile itself. Some factors that could cause actual results to differ materially include economic and operational risks, changes in anticipated earnings, continuation of current contracts, and other factors detailed in the Company's filings with the Securities and Exchange Commission, including its most recent Forms 10-KSB and 10-QSB. The Company forecasts provided above are dynamic and therefore refer only to this release date. The Company does not undertake to update any forecasts that it may make available to the investing public. Please visit

Contact Information

  • Contact:
    For More Information
    Investor Relations
    Crown Dynamics Corporation
    8399 East Indian School Road, Suite 202
    Scottsdale, Arizona 85251
    Office: 1.480.559.9840
    Fax: 866-536-4044